4.4 Review

Clinical applications at ultrahigh field (7T). Where does it make the difference?

Journal

NMR IN BIOMEDICINE
Volume 29, Issue 9, Pages 1316-1334

Publisher

WILEY
DOI: 10.1002/nbm.3272

Keywords

ultrahigh-field MR; 7T; clinical 7-T studies; comparison studies 7T versus 3T; 7-T neurological applications; 7-T whole-body applications; 7-T multi-nuclear spectroscopy and imaging; improved diagnosis for patients at 7T

Funding

  1. Vienna Spots of Excellence of the Vienna Science and Technology Fund (WWTF)
  2. Vienna Advanced Imaging Center (VIACLIC) [FA102A0017]
  3. grant FWF_DACH Programm [1652-B19]
  4. grant FWF-DACH Programm [1690-B19]
  5. Austrian Science Fund (FWF) [P 25246 B24]
  6. Austrian Science Fund (FWF) [I 652, I 690] Funding Source: researchfish

Ask authors/readers for more resources

Presently, three major MR vendors provide commercial 7-T units for clinical research under ethical permission, with the number of operating 7-T systems having increased to over 50. This rapid increase indicates the growing interest in ultrahigh-field MRI because of improved clinical results with regard to morphological as well as functional and metabolic capabilities. As the signal-to-noise ratio scales linearly with the field strength (B-0) of the scanner, the most obvious application at 7T is to obtain higher spatial resolution in the brain, musculoskeletal system and breast. Of specific clinical interest for neuro-applications is the cerebral cortex at 7T, for the detection of changes in cortical structure as a sign of early dementia, as well as for the visualization of cortical microinfarcts and cortical plaques in multiple sclerosis. In the imaging of the hippocampus, even subfields of the internal hippocampal anatomy and pathology can be visualized with excellent resolution. The dynamic and static blood oxygenation level-dependent contrast increases linearly with the field strength, which significantly improves the pre-surgical evaluation of eloquent areas before tumor removal. Using susceptibility-weighted imaging, the plaque-vessel relationship and iron accumulation in multiple sclerosis can be visualized for the first time. Multi-nuclear clinical applications, such as sodium imaging for the evaluation of repair tissue quality after cartilage transplantation and P-31 spectroscopy for the differentiation between non-alcoholic benign liver disease and potentially progressive steatohepatitis, are only possible at ultrahigh fields. Although neuro- and musculoskeletal imaging have already demonstrated the clinical superiority of ultrahigh fields, whole-body clinical applications at 7T are still limited, mainly because of the lack of suitable coils. The purpose of this article was therefore to review the clinical studies that have been performed thus far at 7T, compared with 3T, as well as those studies performed at 7T that cannot be routinely performed at 3T. Copyright (c) 2015 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available